CRISIL reaffirms credit rating on Aarti Drugs bank facilities

The credit rating agency has reaffirmed the company’s long-term rating of Rs1,636cr at CRISIL AA- with a Stable outlook.

May 04, 2021 01:05 IST India Infoline News Service

Aarti Drugs
CRISIL Limited has reaffirmed credit rating on the bank facilities of Aarti Drugs Limited. The credit rating agency has reaffirmed the company’s long-term rating of Rs1,636cr at CRISIL AA- with a Stable outlook. The short-term rating has been reaffirmed at CRISIL A1+.

At around 1.49 pm, Aarti Drugs Ltd was trading at Rs716.55 per piece down by Rs2.6 or 0.36% from its previous closing of Rs719.15 per piece on the BSE.
The scrip opened at Rs729 and has touched a high and low of Rs729 and Rs716 respectively during intraday trade on Tuesday.

Related Story

Open Free Demat Account (Rs699)